Day: September 11, 2023

The new independent company charts enormous success with industry leader Bud Collins at the helm.

BOSTON and DETROIT,

Company appoints Teresa M. Kim, experienced technology finance executive, to oversee finance and accounting funct

– INNA-051 increased early expression of multiple antiviral effector genes compared with placebo and shortened vira

• Enters into a commercialization agreement for SB17, ustekinumab biosimilar candidate, in Europe and North America
• P